Literature DB >> 8531068

Effects of chronic haloperidol on reaction time and errors in a sustained attention task: partial reversal by anticholinergics and by amphetamine.

B J Brockel1, S C Fowler.   

Abstract

The attentional and motor-disruptive effects of low doses of haloperidol were studied in a sustained attention task performed by rats. Five separate groups (n = 7 or 8) of rats were trained to react to a 0.125-sec visual stimulus by executing a nose-poke response within 3 sec of stimulus presentation. Each group of rats received its own dose (0.0, 0.02, 0.04, 0.08 or 0.12 mg/kg) of haloperidol daily for 3 months, and from the 1st week onward dose-effects on reaction time were quite stable across time. Haloperidol treatment disrupted the sustained attention task performance by decreasing the number of behavior-initiated stimulus presentations, decreasing the number of reinforcers earned, increasing the proportion of errors of omission and increasing reaction time to the target stimulus. Testing of challenge drugs began after 23 days of haloperidol treatment. Scopolamine (0.1 and 0.2 mg/kg), benztropine (1.0, 3.0 and 6.0 mg/kg) and d-amphetamine (0.25, 0.5, 1.0 and 2.0 mg/kg) ameliorated haloperidol-induced reaction time slowing, whereas only benztropine and amphetamine lessened haloperidol-induced errors of omission. The 2.0-mg/kg dose of amphetamine by itself produced a significant increase in errors of omission without affecting reaction time. Haloperidol effectively normalized this amphetamine-induced disruption in attention. The results are consistent with a dopaminergic involvement in the expression of both attention and motor processes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8531068

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Developmental effects of dietary n-3 fatty acids on activity and response to novelty.

Authors:  Beth Levant; Troy J Zarcone; Stephen C Fowler
Journal:  Physiol Behav       Date:  2010-05-10

2.  Disruptive effects of prefeeding and haloperidol administration on multiple measures of food-maintained behavior in rats.

Authors:  Yusuke Hayashi; Oliver Wirth
Journal:  Behav Processes       Date:  2011-12-27       Impact factor: 1.777

3.  Differential long-term effects of haloperidol and risperidone on the acquisition and performance of tasks of spatial working and short-term memory and sustained attention in rats.

Authors:  Elizabeth J Hutchings; Jennifer L Waller; Alvin V Terry
Journal:  J Pharmacol Exp Ther       Date:  2013-09-16       Impact factor: 4.030

4.  Methylphenidate attenuates rats' preference for a novel spatial stimulus introduced into a familiar environment: assessment using a force-plate actometer.

Authors:  Stephen C Fowler; Troy J Zarcone; Beth Levant
Journal:  J Neurosci Methods       Date:  2010-03-25       Impact factor: 2.390

5.  Influence of a chronic ultramild stress procedure on decision-making in mice.

Authors:  M C Pardon; F Pérez-Diaz; C Joubert; C Cohen-Salmon
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

6.  Differences in methylphenidate dose response between periadolescent and adult rats in the familiar arena-novel alcove task.

Authors:  Beth Levant; Troy J Zarcone; Paul F Davis; Marlies K Ozias; Stephen C Fowler
Journal:  J Pharmacol Exp Ther       Date:  2010-12-28       Impact factor: 4.030

7.  Prestimulus vigilance predicts response speed in an easy visual discrimination task.

Authors:  Juliane Minkwitz; Maja U Trenner; Christian Sander; Sebastian Olbrich; Abigail J Sheldrick; Peter Schönknecht; Ulrich Hegerl; Hubertus Himmerich
Journal:  Behav Brain Funct       Date:  2011-08-05       Impact factor: 3.759

8.  Toward a Cognitive Neural Prosthesis Using Focused Ultrasound.

Authors:  Matthew E Downs; Tobias Teichert; Amanda Buch; Maria E Karakatsani; Carlos Sierra; Shangshang Chen; Elisa E Konofagou; Vincent P Ferrera
Journal:  Front Neurosci       Date:  2017-11-15       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.